Abstract:Tuberculosis, disease caused by Mycobacterium tuberculosis, is currently the leading cause of death by a single infectious agent worldwide. Early, rapid and accurate identification of M. tuberculosis and the determination of drug susceptibility is essential for the treatment and management of this disease. Tuberculosis diagnosis is mainly based on chest radiography, smear microscopy and bacteriological culture. Smear microscopy has variable sensitivity, mainly in patients co-infected with the human immunodeficiency virus (HIV). Conventional culture for M. tuberculosis isolation, identification and drug susceptibility testing requires several weeks owning to the slow growth of M. tuberculosis. The delay in the time to results drives the prolongation of potentially inappropriate antituberculosis therapy contributing to the emergence of drug resistance, reducing treatment options and increasing treatment duration and associated costs, resulting in increased mortality and morbidity. For these reasons, novel diagnostic methods are need for timely identification of M. tuberculosis and determination of the antibiotic susceptibility profile of the infecting strain. Molecular methods offer enhanced sensitivity and specificity, early detection and the capacity to detect mixed infections. These technologies have improved turnaround time, cost effectiveness and are amenable for point-of-care testing. However, although these methods produce results within hours from sample collection, the phenotypic susceptibility testing is still needed for the determination of drug susceptibility and quantify the susceptibility levels of a given strain towards individual antibiotics. This review presents the history, advances and forthcoming promises in the molecular diagnosis of tuberculosis. An overview on the general principles, diagnostic value and the main advantages and disadvantages of the molecular methods used for the detection and identification of M. tuberculosis and its associated disease, is provided. It will be also discussed how the current phenotypic methods should be used in combination with the genotypic methods for rapid antituberculosis susceptibility testing.

Tuberculosis in the 21th century: Current status of diagnostic methods

Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches

Advances in the molecular diagnosis of tuberculosis: From probes to genomes

Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing

Improving the diagnosis of tuberculosis: old and new laboratory tools

New developments in tuberculosis diagnosis and treatment

[Diagnosis of tuberculosis in developing countries: new perspectives]

Diagnosis of extra pulmonary tuberculosis: An update on novel diagnostic approaches

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

New insight in molecular detection of Mycobacterium tuberculosis

The changing landscape of diagnostic services for tuberculosis

Progress on Diagnosis and Treatment of Latent Tuberculosis Infection

Studies on the diagnostic techniques in HIV/AIDS complicated with mycobacterium tuberculosis infection and resistant phenotype

MODERN PROBLEMS OF TUBERCULOSIS, LABORATORY DIAGNOSTICS

Recent advances in the diagnosis of intestinal tuberculosis

Recent advances in microbiological and molecular biological detection techniques of tuberculous meningitis

New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance

Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination

Tuberculosis: Current state of knowledge: An Epilogue

The laboratory diagnostics of tuberculosis

An Appraisal of PCR-Based Technology in the Detection of Mycobacterium tuberculosis